SREBF1 and fatty liver disease: It reduces liver steatosis by downregulating the lipogenic genes (acetyl-CoA carboxylase (ACC1), FAS, and SREBP-1c) and enhances antioxidant defense by increasing superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) activity.